Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H11NO3 |
| Molecular Weight | 157.1671 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN1C(=O)OC(C)(C)C1=O
InChI
InChIKey=SIGSNYAYBSJATD-UHFFFAOYSA-N
InChI=1S/C7H11NO3/c1-4-8-5(9)7(2,3)11-6(8)10/h4H2,1-3H3
| Molecular Formula | C7H11NO3 |
| Molecular Weight | 157.1671 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| PRALIMAP: study protocol for a high school-based, factorial cluster randomised interventional trial of three overweight and obesity prevention strategies. | 2010-12-06 |
|
| A process evaluation of a "physical activity pathway" in the primary care setting. | 2010-08-09 |
|
| Early incidence of occupational asthma among young bakers, pastry-makers and hairdressers: design of a retrospective cohort study. | 2010-04-26 |
|
| [Securitization of the bi-site radiotherapy activity as part of the resumption of treatments in the Hospital of Epinal by the team of Alexis Vautrin Nancy Cancer Center]. | 2009-12 |
|
| TABADO: "evaluation of a smoking cessation program among adolescents in vocational training centers": study protocol. | 2009-11-13 |
|
| [Report of the mission commissioned by the Ministry of Health to the French Society of Radiation Oncology]. | 2009-06 |
|
| [Quality & Safety in radiotherapy: advocacy for a professional strategy]. | 2008-11 |
|
| Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD. | 2008 |
|
| [Epinal radiotherapy accident: passed, present, future]. | 2007-11 |
|
| Lessons from Epinal. | 2007-10 |
|
| Summary version of the Standards, Options and Recommendations for nonmetastatic breast cancer (updated January 2001). | 2003-08 |
|
| Sequential or alternating administration of docetaxel (Taxotere) combined with FEC in metastatic breast cancer: a randomised phase II trial. | 2002-03-04 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 17:54:03 GMT 2025
by
admin
on
Mon Mar 31 17:54:03 GMT 2025
|
| Record UNII |
I0F8O700BB
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
N03AC03
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
||
|
WHO-VATC |
QN03AC03
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB13728MIG
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
27168
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
Ethadione
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
100000078984
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
208-297-0
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
1072
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
CHEMBL93047
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
m5043
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB13799
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
520-77-4
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
C007637
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
I0F8O700BB
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
10630
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY | |||
|
DTXSID90199972
Created by
admin on Mon Mar 31 17:54:03 GMT 2025 , Edited by admin on Mon Mar 31 17:54:03 GMT 2025
|
PRIMARY |